• Non ci sono risultati.

WHO Collaborating Centre for Cancer Early Detection and Screening

N/A
N/A
Protected

Academic year: 2022

Condividi "WHO Collaborating Centre for Cancer Early Detection and Screening"

Copied!
1
0
0

Testo completo

(1)

WHO Collaborating Centre for Cancer Early Detection and Screening

Early Detection and Screening Programmes in the Mediterranean Countries Turin, 11 September 2014

Aula Magna Dogliotti, Ospedale Molinette. Corso Bramante 88.

Programme 1.00 – 1.30 pm Institutional greetings

1.30 – 2.00 pm The role of WHO in cancer control

(A. Ullrich, World Health Organization HQ)

2.00 – 2.30 pm International cooperation: Approaches and strategies for cancer control

(L. Von Karsa, International Agency for Research on Cancer - F. De Bels, French National Cancer Institute)

2.30 – 3.00 pm The Italian Ministry of Health and its cooperation policies in the Mediterranean basin (P. Rossi, Italian MOH)

3.00 – 3.30 pm Cancer prevention strategies in low and middle income countries (R. Sankaranarayan, IARC)

3.30 – 4.00 pm The WHO Collaborating Center for Cancer Early Detection and Screening (N. Segnan, Piedmont Reference Center for Epidemiology and Cancer Prevention)

4.00 – 4.30 pm The Euromed Cancer Project (G. Salamina, ASL TO1)

4.30 – 5.00 pm Early detection and screening programmes in the Mediterranean countries (L. Giordano, CPO Piemonte)

5.00 - 5.30 pm The Euromed Cancer network activities: past and future experiences (L. Bisanti, CPO Piemonte)

5.30 – 6.00 pm Cooperation strategies for cancer control in two Mediterranean countries (V. Jovanovic, Serbian Institut of Public Health - O. Nimri, Cancer Prevention Department, Amman, Jordan )

6.00– 6.30 pm Cancer registries and the implementation of organized screening programmes: An international network

(R. Zanetti, Piedmont Cancer Registry)

6.30 - 7.00 pm Discussion and conclusions: Inter-institutional perspectives in the international fight against cancer

(N. Segnan, A. Ullrich)

7.00 – 7.30 pm Test

The conference will be attended by representatives from World Health Organization, International Agency for Research on Cancer, Piedmont Region, countries participating to the Euromed Cancer Network and other national and international entities involved in the fight against cancer.

The conference is recommended by the European School of Oncology

Riferimenti

Documenti correlati

K E Y W O R D S Cancer research Mixed-method systematic review Nurses' perceptions Nurses' priorities Nursing societies Patients' perceptions Patients' priorities Research

contain an elevated numbers of proteins that can participate to signal generation (e.g.: uorescence, charge distribution) hiding the signal coming from (few) specic

In its recent evaluation from March 2015, the International Agency for Cancer Research (IARC), as the specialized cancer agency of the World Health Organization (WHO), came to

• La forza delle raccomandazioni dipendeva dal disegno e in parte dalla qualità metodologica disegno e in parte dalla qualità metodologica degli studi … quindi …. • Ridondanze

The International Agency for Research on Cancer (IARC), the specialized cancer agency of the World Health Organization (WHO), has a pivotal role in the production and evaluation

non-polyposis colorectal cancer may well develop colorectal cancers before the age of 50 and therefore screening for these high-risk individuals needs to be tailored to their

ECPC, with the support of MEP Elisabetta Gardini, will organise a press conference at the European Parliament to celebrate the World Cancer Day 2015.. One year after the launch of

In the United Kingdom, the Protect (Prostate Testing for Cancer and Treatment) study is a randomized controlled trial of treatment effectiveness in men with clinically